Armenia's Ministry of State Revenues and the country's largest drugimporters have agreed that medicines will be sold in the country in first-quarter 2001 at December 2000 prices, reports the Snark news agency.
Drug prices rose 35%-40% at the start of the year after 20% value-added tax was introduced. During first-quarter 2001, the government will monitor the drugs market closely and will, if necessary, make changes to the law on VAT on medicines in April.
The Minister of State Revenues, Andranik Manuyan, said the importers' agreement to sell at December 2000 prices was praiseworthy, as they may sustain financial losses as a result. He also said that, of 6,000 brands of drugs sold in Armenia, only 2,500 are registered, and many drug firms make huge profits, allegedly by faking invoices, which his Ministry will address. Armenia imported drugs worth $40 million last year.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze